Trial intelligence / Profile preview

Subcutaneous methotrexate versus placebo in moderate to severe psoriasis vulgaris

2012-002716-10Phase 3Completed

Sponsor

Prof. Dr. Kristian Reich

Start

Nov 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1